Amit Jaiswal is an Associate Professor in the School of Biosciences and Bioengineering at the Indian Institute of Technology (IIT) Mandi, India. In 2008, he graduated with a B.Tech. in Biotechnology from Heritage Institute of Technology Kolkata, and in 2010, he earned an MTech. in Biotechnology from Indian Institute of Technology Guwahati, India. Thereafter, he received his PhD. degree in Nanotechnology from the Indian Institute of Technology Guwahati in 2013. He completed his post-doctoral studies at the Technion – Israel Institute of Technology in Haifa, Israel and Washington University in St. Louis, Missouri, USA. In 2014, Dr. Jaiswal began his career at IIT Mandi as an Assistant Professor, and he is currently an Associate Professor there. His research interests are in the fields of materials chemistry, nanobiotechnology, and biomaterials. In recognition of his work, he was given the Department of Atomic Energy (DAE) Young Scientist Research Award in 2017, and the Manipal Academy of Higher Education (MAHE) Young Scientist Award in 2018. Additionally, in 2020, he was chosen to be an Associate of the Indian Academy of Sciences, Bangalore. For his research accomplishments he was awarded with the Indian National Science Academy (INSA) 2021 medal for young scientists, and his research team also won the Gandhian Young Technological Innovation (GYTI) 2021 appreciation award. He has authored five book chapters and more than 40 peer-reviewed journal publications. He can be found on Twitter @AJnanobio.
Read Amit’s Emerging Investigators article, ‘Antimicrobial Mechanisms of Biomaterials: From Macro to Nano’ featured in the Biomaterials Science Emerging Investigators series 2022.
Visit the group webpage to find out more about Amit’s research:
How do you feel about Biomaterials Science as a place to publish research on this topic?
I want to start by thanking the editorial team of the journal Biomaterials Science for considering our manuscript for publication in this journal. Biomaterials Scienceis a fast-growing journal which has seen a steady growth over the past couple of years in terms of readership and quality of papers published. It is one of the Q1 journals in the field of biomedical engineering and biomaterials research and is a preferred journal for a lot of scientists worldwide working in this field. So, getting our paper accepted in Biomaterials Scienceis a great satisfaction for me and my team. Our manuscript, which provides a detailed discussion on the fundamentals of interaction of biomaterials (from macroscale to nanoscale) with pathogens like bacteria and viruses, is a topic which is very well suited and apt for the wide readership of this journal. Having this paper in Biomaterials Science will surely increase its visibility to the scientific community at large and I believe that the readers will greatly benefit from this paper.
